Accelerated vs. conventional collagen cross‑linking for infectious keratitis

Barac,Ileana Ramona; Balta,George; Zemba,Mihail; Branduse,Lacramioara; Mehedintu,Claudia; Burcea,Marian; Barac,Diana Andreea; Branisteanu,Daniel Constantin; Balta,Florian

doi:10.3892/etm.2021.9716

Accelerated vs. conventional collagen cross‑linking for infectious keratitis

Authors:
- Ileana Ramona Barac
- George Balta
- Mihail Zemba
- Lacramioara Branduse
- Claudia Mehedintu
- Marian Burcea
- Diana Andreea Barac
- Daniel Constantin Branisteanu
- Florian Balta
View Affiliations

Affiliations: Department of Ophthalmology, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania, Department of Ophthalmology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iași, Romania
Published online on: January 26, 2021 https://doi.org/10.3892/etm.2021.9716
Article Number: 285
Copyright: © Barac et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Infectious keratitis represents a serious concern for ophthalmologists, with a progressively growing incidence in the last few years. In this prospective comparative study, we evaluated two groups of patients with infectious keratitis or corneal ulcer resistant to antimicrobial and antifungal therapy, treated respectively with conventional and accelerated photoactivated chromophore collagen cross‑linking. Eight patients were assigned to each group and they were monitored for 12 months. We investigated the differences between groups, comparing on one side the mean of the quantitative variables using the t‑test and on the other side the frequencies of qualitative variables using the Fisher exact test. The time to healing for the group treated with conventional cross‑linking was 2 days longer than for the group undergoing accelerated cross‑linking (34.9±11.4 vs. 32.9±9.4 days), a difference that did not reach statistical significance (P=0.708). We conclude that the accelerated protocol is as safe and efficient as the classic procedure. The accelerated protocol has an important advantage, both for the doctor and the patient, of being time sparing (the time for accelerated cross‑linking is 3 times shorter than in the case of the conventional protocol).

View Figures

View References

1	Bongomin F, Gago S, Oladele RO and Denning DW: Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 3(57)2017.PubMed/NCBI View Article : Google Scholar
2	World Health Organization: Global Priority List of Antibiotic Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Available from: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf.
3	Acharya Y, Acharya B and Karki P: Fungal keratitis: Study of increasing trend and common determinants. Nepal J Epidemiol. 7:685–693. 2017.PubMed/NCBI View Article : Google Scholar
4	Brown L, Leck A, Gichangi M, Burton M and Denning D: The global incidence and diagnosis of fungal keratitis. Lancet 2020.
5	Mehedintu C, Bratila E, Cirstoiu M, Petca A, Brinduse LA, Berceanu C, Barac RI, Andreescu CV, Petca RC, Sandru F, et al: Evaluation of effectiveness and tolerability of boric acid in the treatment of vaginal infection with candida species. Rev Chim. 70:2375–2378. 2019.
6	Neu HC: The crisis in antibiotic resistance. Science. 257:1064–1073. 1992.PubMed/NCBI View Article : Google Scholar
7	Chan TC, Lau TW, Lee JW, Wong IY, Jhanji V and Wong RL: Corneal collagen cross-linking for infectious keratitis: An update of clinical studies. Acta Ophthalmol. 93:689–696. 2015.PubMed/NCBI View Article : Google Scholar
8	O'Brart DP: Corneal collagen cross-linking: A review. J Optom. 7:113–124. 2013.PubMed/NCBI View Article : Google Scholar
9	Panda A, Krishna SN and Kumar S: Photoactivated riboflavin therapy of refractory corneal ulcers. Cornea. 31:1210–1213. 2012.PubMed/NCBI View Article : Google Scholar
10	Bettis DI, Hsu M and Moshirfar M: Corneal collagen cross-linking for nonectatic disorders: A systematic review. J Refract Surg. 28:798–807. 2012.PubMed/NCBI View Article : Google Scholar
11	Spoerl E, Wollensak G and Seiler T: Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 29:35–40. 2004.PubMed/NCBI View Article : Google Scholar
12	Del Buey MA, Cristóbal JA, Casas P, Goñi P, Clavel A, Mínguez E, Lanchares E, García A and Calvo B: Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol. 153:399–404. 2012.PubMed/NCBI View Article : Google Scholar
13	Bamdad S, Malekhosseini H and Khosravi A: Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers. Cornea. 34:402–406. 2015.PubMed/NCBI View Article : Google Scholar
14	Shetty R, Nagaraja H, Jayadev C, Shivanna Y and Kugar T: Collagen crosslinking in the management of advanced nonresolving microbial keratitis. Br J Ophthalmol. 98:1033–1035. 2014.PubMed/NCBI View Article : Google Scholar
15	Ramona BI, Catalina C, Andrei M, Daciana S and Calin T: Collagen crosslinking in the management of microbial keratitis. Rom J Ophthalmol. 60:28–30. 2016.PubMed/NCBI
16	Richoz O, Kling S, Hoogewoud F, Hammer A, Tabibian D, Francois P, Schrenzel J and Hafezi F: Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J Refract Surg. 30:850–854. 2014.PubMed/NCBI View Article : Google Scholar
17	Tabibian D, Richoz O, Riat A, Schrenzel J and Hafezi F: Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis. J Refract Surg. 30:855–857. 2014.PubMed/NCBI View Article : Google Scholar
18	Makdoumi K, Mortensen J and Crafoord S: Infectious keratitis treated with corneal crosslinking. Cornea. 29:1353–1358. 2010.PubMed/NCBI View Article : Google Scholar
19	Said DG, Elalfy MS, Gatzioufas Z, El-Zakzouk ES, Hassan MA, Saif MY, Zaki AA, Dua HS and Hafezi F: Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 121:1377–1382. 2014.PubMed/NCBI View Article : Google Scholar
20	Ting DS, Henein C, Said DG and Dua HS: Photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL): A systematic review and meta-analysis. Ocul Surf. 17:624–634. 2019.PubMed/NCBI View Article : Google Scholar
21	Rapuano P, Scanameo AH, Amponin DE, Paulose SA, Zyablitskaya M, Takaoka A, Suh LH, Nagasaki T, Trokel SL and Paik DC: Antimicrobial studies using the therapeutic tissue cross-linking agent, sodium hydroxymethylglycinate: Implication for treating infectious keratitis. Invest Ophthalmol Vis Sci. 59:332–337. 2018.PubMed/NCBI View Article : Google Scholar
22	Kasparova EA, Fedorov AA and Yang B: Clinical results of modified crosslinking in the treatment of purulent keratitis and corneal ulcers. Vestn Oftalmol. 136:64–73. 2020.PubMed/NCBI View Article : Google Scholar : (In Russian).